APO Research

APO RESEARCH · REPORT

Helicobacter Pylori Antigen Test

Selected research

Market Outlook & Growth Opportunities

Global Helicobacter Pylori Antigen Test Market Outlook and Growth Opportunities 2026

Market perspective

The global Helicobacter Pylori Antigen Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Helicobacter Pylori Antigen Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Helicobacter Pylori Antigen Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Helicobacter Pylori Antigen Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Helicobacter Pylori Antigen Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Helicobacter Pylori Antigen Test market include Abbott Laboratories, Thermo Fisher Scientific, CerTest Biotec, GUANGZHOU WONDFO BIOTECH CO.,LTD, Getein Biotech,Inc, Zhejiang Orient Gene Biotech Co.,Ltd., Denka Company Limited, ACON Laboratories Inc and Coris Bioconcept SRL, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Helicobacter Pylori Antigen Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Helicobacter Pylori Antigen Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Helicobacter Pylori Antigen Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Helicobacter Pylori Antigen Test market.

Helicobacter Pylori Antigen Test Segment by Company

Abbott Laboratories

Thermo Fisher Scientific

CerTest Biotec

GUANGZHOU WONDFO BIOTECH CO.,LTD

Getein Biotech,Inc

Zhejiang Orient Gene Biotech Co.,Ltd.

Denka Company Limited

ACON Laboratories Inc

Coris Bioconcept SRL

Biosynex SA

CTK Biotech, Inc.

Humasis Co., Ltd.

Assure Tech(HangZhou) Co., Ltd.

Hangzhou Biotest Biotech Co.,Ltd.

Xiamen Boson Biotech

MP Biomedicals

Diagnostic Automation

DRG Diagnostics

Epitope Diagnostics

SD Biosensor

DiaSorin

QuidelOrtho

Helicobacter Pylori Antigen Test Segment by Type

Carbon-13 Breath Test

Carbon-14 Breath Test

Helicobacter Pylori Antigen Test Segment by Application

Medical and Health

Public Health

Medical Examination Services

Other

Helicobacter Pylori Antigen Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Helicobacter Pylori Antigen Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Helicobacter Pylori Antigen Test key companies, revenue, market share, and recent developments.

3. To split the Helicobacter Pylori Antigen Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Helicobacter Pylori Antigen Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Helicobacter Pylori Antigen Test significant trends, drivers, influence factors in global and regions.

6. To analyze Helicobacter Pylori Antigen Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Antigen Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Antigen Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Antigen Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Helicobacter Pylori Antigen Test industry.

Chapter 3: Detailed analysis of Helicobacter Pylori Antigen Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Helicobacter Pylori Antigen Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Helicobacter Pylori Antigen Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Helicobacter Pylori Antigen Test Industry Trends Table 2. Helicobacter Pylori Antigen Test Industry Drivers Table 3. Helicobacter Pylori Antigen Test Industry Opportunities and Challenges Table 4. Helicobacter Pylori Antigen Test Industry Restraints Table 5. Global Helicobacter Pylori Antigen Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Helicobacter Pylori Antigen Test Revenue Share by Company (2021-2026) Table 7. Global Helicobacter Pylori Antigen Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Helicobacter Pylori Antigen Test Key Company Manufacturing Base & Headquarters Table 9. Global Helicobacter Pylori Antigen Test Company, Product Type & Application Table 10. Global Helicobacter Pylori Antigen Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Helicobacter Pylori Antigen Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Carbon-13 Breath Test Table 15. Significant Companies of Carbon-14 Breath Test Table 16. Global Helicobacter Pylori Antigen Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Helicobacter Pylori Antigen Test Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Helicobacter Pylori Antigen Test Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Helicobacter Pylori Antigen Test Sales Value Share by Type (2021-2026) Table 20. Global Helicobacter Pylori Antigen Test Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical and Health Table 22. Significant Companies of Public Health Table 23. Significant Companies of Medical Examination Services Table 24. Significant Companies of Other Table 25. Global Helicobacter Pylori Antigen Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Helicobacter Pylori Antigen Test Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Helicobacter Pylori Antigen Test Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Helicobacter Pylori Antigen Test Sales Value Share by Application (2021-2026) Table 29. Global Helicobacter Pylori Antigen Test Sales Value Share by Application (2027-2032) Table 30. Global Helicobacter Pylori Antigen Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Helicobacter Pylori Antigen Test Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Helicobacter Pylori Antigen Test Sales Value Share by Region (2021-2026) Table 33. Global Helicobacter Pylori Antigen Test Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Helicobacter Pylori Antigen Test Sales Value Share by Region (2027-2032) Table 35. Global Helicobacter Pylori Antigen Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Helicobacter Pylori Antigen Test Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Helicobacter Pylori Antigen Test Sales Value Market Share by Country (2021-2026) Table 38. Global Helicobacter Pylori Antigen Test Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Helicobacter Pylori Antigen Test Sales Value Market Share by Country (2027-2032) Table 40. Abbott Laboratories Company Information Table 41. Abbott Laboratories Business Overview Table 42. Abbott Laboratories Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Abbott Laboratories Helicobacter Pylori Antigen Test Product Portfolio Table 44. Abbott Laboratories Recent Development Table 45. Thermo Fisher Scientific Company Information Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Thermo Fisher Scientific Helicobacter Pylori Antigen Test Product Portfolio Table 49. Thermo Fisher Scientific Recent Development Table 50. CerTest Biotec Company Information Table 51. CerTest Biotec Business Overview Table 52. CerTest Biotec Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. CerTest Biotec Helicobacter Pylori Antigen Test Product Portfolio Table 54. CerTest Biotec Recent Development Table 55. GUANGZHOU WONDFO BIOTECH CO.,LTD Company Information Table 56. GUANGZHOU WONDFO BIOTECH CO.,LTD Business Overview Table 57. GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Product Portfolio Table 59. GUANGZHOU WONDFO BIOTECH CO.,LTD Recent Development Table 60. Getein Biotech,Inc Company Information Table 61. Getein Biotech,Inc Business Overview Table 62. Getein Biotech,Inc Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Getein Biotech,Inc Helicobacter Pylori Antigen Test Product Portfolio Table 64. Getein Biotech,Inc Recent Development Table 65. Zhejiang Orient Gene Biotech Co.,Ltd. Company Information Table 66. Zhejiang Orient Gene Biotech Co.,Ltd. Business Overview Table 67. Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio Table 69. Zhejiang Orient Gene Biotech Co.,Ltd. Recent Development Table 70. Denka Company Limited Company Information Table 71. Denka Company Limited Business Overview Table 72. Denka Company Limited Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Denka Company Limited Helicobacter Pylori Antigen Test Product Portfolio Table 74. Denka Company Limited Recent Development Table 75. ACON Laboratories Inc Company Information Table 76. ACON Laboratories Inc Business Overview Table 77. ACON Laboratories Inc Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. ACON Laboratories Inc Helicobacter Pylori Antigen Test Product Portfolio Table 79. ACON Laboratories Inc Recent Development Table 80. Coris Bioconcept SRL Company Information Table 81. Coris Bioconcept SRL Business Overview Table 82. Coris Bioconcept SRL Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Coris Bioconcept SRL Helicobacter Pylori Antigen Test Product Portfolio Table 84. Coris Bioconcept SRL Recent Development Table 85. Biosynex SA Company Information Table 86. Biosynex SA Business Overview Table 87. Biosynex SA Helicobacter Pylori Antigen Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Biosynex SA Helicobacter Pylori Antigen Test Product Portfolio Table 89. Biosynex SA Recent Development Table 90. CTK Biotech, Inc. Company Information Table 91. CTK Biotech, Inc. Business Overview Table 92. CTK Biotech, Inc. Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CTK Biotech, Inc. Helicobacter Pylori Antigen Test Product Portfolio Table 94. CTK Biotech, Inc. Recent Development Table 95. Humasis Co., Ltd. Company Information Table 96. Humasis Co., Ltd. Business Overview Table 97. Humasis Co., Ltd. Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Humasis Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio Table 99. Humasis Co., Ltd. Recent Development Table 100. Assure Tech(HangZhou) Co., Ltd. Company Information Table 101. Assure Tech(HangZhou) Co., Ltd. Business Overview Table 102. Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio Table 104. Assure Tech(HangZhou) Co., Ltd. Recent Development Table 105. Hangzhou Biotest Biotech Co.,Ltd. Company Information Table 106. Hangzhou Biotest Biotech Co.,Ltd. Business Overview Table 107. Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio Table 109. Hangzhou Biotest Biotech Co.,Ltd. Recent Development Table 110. Xiamen Boson Biotech Company Information Table 111. Xiamen Boson Biotech Business Overview Table 112. Xiamen Boson Biotech Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Xiamen Boson Biotech Helicobacter Pylori Antigen Test Product Portfolio Table 114. Xiamen Boson Biotech Recent Development Table 115. MP Biomedicals Company Information Table 116. MP Biomedicals Business Overview Table 117. MP Biomedicals Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. MP Biomedicals Helicobacter Pylori Antigen Test Product Portfolio Table 119. MP Biomedicals Recent Development Table 120. Diagnostic Automation Company Information Table 121. Diagnostic Automation Business Overview Table 122. Diagnostic Automation Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Diagnostic Automation Helicobacter Pylori Antigen Test Product Portfolio Table 124. Diagnostic Automation Recent Development Table 125. DRG Diagnostics Company Information Table 126. DRG Diagnostics Business Overview Table 127. DRG Diagnostics Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. DRG Diagnostics Helicobacter Pylori Antigen Test Product Portfolio Table 129. DRG Diagnostics Recent Development Table 130. Epitope Diagnostics Company Information Table 131. Epitope Diagnostics Business Overview Table 132. Epitope Diagnostics Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Epitope Diagnostics Helicobacter Pylori Antigen Test Product Portfolio Table 134. Epitope Diagnostics Recent Development Table 135. SD Biosensor Company Information Table 136. SD Biosensor Business Overview Table 137. SD Biosensor Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. SD Biosensor Helicobacter Pylori Antigen Test Product Portfolio Table 139. SD Biosensor Recent Development Table 140. DiaSorin Company Information Table 141. DiaSorin Business Overview Table 142. DiaSorin Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. DiaSorin Helicobacter Pylori Antigen Test Product Portfolio Table 144. DiaSorin Recent Development Table 145. QuidelOrtho Company Information Table 146. QuidelOrtho Business Overview Table 147. QuidelOrtho Helicobacter Pylori Antigen Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. QuidelOrtho Helicobacter Pylori Antigen Test Product Portfolio Table 149. QuidelOrtho Recent Development Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Helicobacter Pylori Antigen Test Product Image Figure 2. Global Helicobacter Pylori Antigen Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Helicobacter Pylori Antigen Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Helicobacter Pylori Antigen Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Carbon-13 Breath Test Image Figure 8. Carbon-14 Breath Test Image Figure 9. Global Helicobacter Pylori Antigen Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Helicobacter Pylori Antigen Test Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Helicobacter Pylori Antigen Test Sales Value Share by Type (2021-2032) Figure 12. Medical and Health Image Figure 13. Public Health Image Figure 14. Medical Examination Services Image Figure 15. Other Image Figure 16. Global Helicobacter Pylori Antigen Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Helicobacter Pylori Antigen Test Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Helicobacter Pylori Antigen Test Sales Value Share by Application (2021-2032) Figure 19. Global Helicobacter Pylori Antigen Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Helicobacter Pylori Antigen Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Helicobacter Pylori Antigen Test Sales Value (2021-2032) & (US$ Million) Figure 22. North America Helicobacter Pylori Antigen Test Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Helicobacter Pylori Antigen Test Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Helicobacter Pylori Antigen Test Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Helicobacter Pylori Antigen Test Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Helicobacter Pylori Antigen Test Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Helicobacter Pylori Antigen Test Sales Value (2021-2032) & (US$ Million) Figure 28. South America Helicobacter Pylori Antigen Test Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Helicobacter Pylori Antigen Test Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Helicobacter Pylori Antigen Test Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Carbon-13 Breath Test
  • Carbon-14 Breath Test
Applications
  • Medical and Health
  • Public Health
  • Medical Examination Services
  • Other
Companies covered
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • CerTest Biotec
  • GUANGZHOU WONDFO BIOTECH CO.,LTD
  • Getein Biotech,Inc
  • Zhejiang Orient Gene Biotech Co.,Ltd.
  • Denka Company Limited
  • ACON Laboratories Inc
  • Coris Bioconcept SRL
  • Biosynex SA
  • CTK Biotech, Inc.
  • Humasis Co., Ltd.
  • Assure Tech(HangZhou) Co., Ltd.
  • Hangzhou Biotest Biotech Co.,Ltd.
  • Xiamen Boson Biotech
  • MP Biomedicals
  • Diagnostic Automation
  • DRG Diagnostics
  • Epitope Diagnostics
  • SD Biosensor
  • DiaSorin
  • QuidelOrtho

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Helicobacter Pylori Antigen Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Helicobacter Pylori Antigen Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Helicobacter Pylori Antigen Test Market Dynamics
  1. 2.1 Helicobacter Pylori Antigen Test Industry Trends
  2. 2.2 Helicobacter Pylori Antigen Test Industry Drivers
  3. 2.3 Helicobacter Pylori Antigen Test Industry Opportunities and Challenges
  4. 2.4 Helicobacter Pylori Antigen Test Industry Restraints
3 Helicobacter Pylori Antigen Test Market by Company
  1. 3.1 Global Helicobacter Pylori Antigen Test Company Revenue Ranking in 2025
  2. 3.2 Global Helicobacter Pylori Antigen Test Revenue by Company (2021-2026)
  3. 3.3 Global Helicobacter Pylori Antigen Test Company Ranking (2024-2026)
  4. 3.4 Global Helicobacter Pylori Antigen Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Helicobacter Pylori Antigen Test Company Product Type and Application
  6. 3.6 Global Helicobacter Pylori Antigen Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Helicobacter Pylori Antigen Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Helicobacter Pylori Antigen Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Helicobacter Pylori Antigen Test Market by Type
  1. 4.1 Helicobacter Pylori Antigen Test Type Introduction
  2. 4.1.1 Carbon-13 Breath Test
  3. 4.1.2 Carbon-14 Breath Test
  4. 4.2 Global Helicobacter Pylori Antigen Test Sales Value by Type
  5. 4.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Type (2021-2032)
  7. 4.2.3 Global Helicobacter Pylori Antigen Test Sales Value Share by Type (2021-2032)
5 Helicobacter Pylori Antigen Test Market by Application
  1. 5.1 Helicobacter Pylori Antigen Test Application Introduction
  2. 5.1.1 Medical and Health
  3. 5.1.2 Public Health
  4. 5.1.3 Medical Examination Services
  5. 5.1.4 Other
  6. 5.2 Global Helicobacter Pylori Antigen Test Sales Value by Application
  7. 5.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Application (2021-2032)
  9. 5.2.3 Global Helicobacter Pylori Antigen Test Sales Value Share by Application (2021-2032)
6 Helicobacter Pylori Antigen Test Regional Value Analysis
  1. 6.1 Global Helicobacter Pylori Antigen Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Helicobacter Pylori Antigen Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Helicobacter Pylori Antigen Test Sales Value (2021-2032)
  7. 6.3.2 North America Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Helicobacter Pylori Antigen Test Sales Value (2021-2032)
  10. 6.4.2 Europe Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Helicobacter Pylori Antigen Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Helicobacter Pylori Antigen Test Sales Value (2021-2032)
  16. 6.6.2 South America Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Helicobacter Pylori Antigen Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Helicobacter Pylori Antigen Test Sales Value Share by Country, 2025 VS 2032
7 Helicobacter Pylori Antigen Test Country-level Value Analysis
  1. 7.1 Global Helicobacter Pylori Antigen Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Helicobacter Pylori Antigen Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Helicobacter Pylori Antigen Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Helicobacter Pylori Antigen Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Helicobacter Pylori Antigen Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Helicobacter Pylori Antigen Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Helicobacter Pylori Antigen Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Helicobacter Pylori Antigen Test Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Helicobacter Pylori Antigen Test Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 CerTest Biotec
  14. 8.3.1 CerTest Biotec Company Information
  15. 8.3.2 CerTest Biotec Business Overview
  16. 8.3.3 CerTest Biotec Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CerTest Biotec Helicobacter Pylori Antigen Test Product Portfolio
  18. 8.3.5 CerTest Biotec Recent Developments
  19. 8.4 GUANGZHOU WONDFO BIOTECH CO.,LTD
  20. 8.4.1 GUANGZHOU WONDFO BIOTECH CO.,LTD Company Information
  21. 8.4.2 GUANGZHOU WONDFO BIOTECH CO.,LTD Business Overview
  22. 8.4.3 GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GUANGZHOU WONDFO BIOTECH CO.,LTD Helicobacter Pylori Antigen Test Product Portfolio
  24. 8.4.5 GUANGZHOU WONDFO BIOTECH CO.,LTD Recent Developments
  25. 8.5 Getein Biotech,Inc
  26. 8.5.1 Getein Biotech,Inc Company Information
  27. 8.5.2 Getein Biotech,Inc Business Overview
  28. 8.5.3 Getein Biotech,Inc Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Getein Biotech,Inc Helicobacter Pylori Antigen Test Product Portfolio
  30. 8.5.5 Getein Biotech,Inc Recent Developments
  31. 8.6 Zhejiang Orient Gene Biotech Co.,Ltd.
  32. 8.6.1 Zhejiang Orient Gene Biotech Co.,Ltd. Company Information
  33. 8.6.2 Zhejiang Orient Gene Biotech Co.,Ltd. Business Overview
  34. 8.6.3 Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zhejiang Orient Gene Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio
  36. 8.6.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments
  37. 8.7 Denka Company Limited
  38. 8.7.1 Denka Company Limited Company Information
  39. 8.7.2 Denka Company Limited Business Overview
  40. 8.7.3 Denka Company Limited Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Denka Company Limited Helicobacter Pylori Antigen Test Product Portfolio
  42. 8.7.5 Denka Company Limited Recent Developments
  43. 8.8 ACON Laboratories Inc
  44. 8.8.1 ACON Laboratories Inc Company Information
  45. 8.8.2 ACON Laboratories Inc Business Overview
  46. 8.8.3 ACON Laboratories Inc Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ACON Laboratories Inc Helicobacter Pylori Antigen Test Product Portfolio
  48. 8.8.5 ACON Laboratories Inc Recent Developments
  49. 8.9 Coris Bioconcept SRL
  50. 8.9.1 Coris Bioconcept SRL Company Information
  51. 8.9.2 Coris Bioconcept SRL Business Overview
  52. 8.9.3 Coris Bioconcept SRL Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Coris Bioconcept SRL Helicobacter Pylori Antigen Test Product Portfolio
  54. 8.9.5 Coris Bioconcept SRL Recent Developments
  55. 8.10 Biosynex SA
  56. 8.10.1 Biosynex SA Company Information
  57. 8.10.2 Biosynex SA Business Overview
  58. 8.10.3 Biosynex SA Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biosynex SA Helicobacter Pylori Antigen Test Product Portfolio
  60. 8.10.5 Biosynex SA Recent Developments
  61. 8.11 CTK Biotech, Inc.
  62. 8.11.1 CTK Biotech, Inc. Company Information
  63. 8.11.2 CTK Biotech, Inc. Business Overview
  64. 8.11.3 CTK Biotech, Inc. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CTK Biotech, Inc. Helicobacter Pylori Antigen Test Product Portfolio
  66. 8.11.5 CTK Biotech, Inc. Recent Developments
  67. 8.12 Humasis Co., Ltd.
  68. 8.12.1 Humasis Co., Ltd. Company Information
  69. 8.12.2 Humasis Co., Ltd. Business Overview
  70. 8.12.3 Humasis Co., Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Humasis Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio
  72. 8.12.5 Humasis Co., Ltd. Recent Developments
  73. 8.13 Assure Tech(HangZhou) Co., Ltd.
  74. 8.13.1 Assure Tech(HangZhou) Co., Ltd. Company Information
  75. 8.13.2 Assure Tech(HangZhou) Co., Ltd. Business Overview
  76. 8.13.3 Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Assure Tech(HangZhou) Co., Ltd. Helicobacter Pylori Antigen Test Product Portfolio
  78. 8.13.5 Assure Tech(HangZhou) Co., Ltd. Recent Developments
  79. 8.14 Hangzhou Biotest Biotech Co.,Ltd.
  80. 8.14.1 Hangzhou Biotest Biotech Co.,Ltd. Company Information
  81. 8.14.2 Hangzhou Biotest Biotech Co.,Ltd. Business Overview
  82. 8.14.3 Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hangzhou Biotest Biotech Co.,Ltd. Helicobacter Pylori Antigen Test Product Portfolio
  84. 8.14.5 Hangzhou Biotest Biotech Co.,Ltd. Recent Developments
  85. 8.15 Xiamen Boson Biotech
  86. 8.15.1 Xiamen Boson Biotech Company Information
  87. 8.15.2 Xiamen Boson Biotech Business Overview
  88. 8.15.3 Xiamen Boson Biotech Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Xiamen Boson Biotech Helicobacter Pylori Antigen Test Product Portfolio
  90. 8.15.5 Xiamen Boson Biotech Recent Developments
  91. 8.16 MP Biomedicals
  92. 8.16.1 MP Biomedicals Company Information
  93. 8.16.2 MP Biomedicals Business Overview
  94. 8.16.3 MP Biomedicals Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  95. 8.16.4 MP Biomedicals Helicobacter Pylori Antigen Test Product Portfolio
  96. 8.16.5 MP Biomedicals Recent Developments
  97. 8.17 Diagnostic Automation
  98. 8.17.1 Diagnostic Automation Company Information
  99. 8.17.2 Diagnostic Automation Business Overview
  100. 8.17.3 Diagnostic Automation Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Diagnostic Automation Helicobacter Pylori Antigen Test Product Portfolio
  102. 8.17.5 Diagnostic Automation Recent Developments
  103. 8.18 DRG Diagnostics
  104. 8.18.1 DRG Diagnostics Company Information
  105. 8.18.2 DRG Diagnostics Business Overview
  106. 8.18.3 DRG Diagnostics Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  107. 8.18.4 DRG Diagnostics Helicobacter Pylori Antigen Test Product Portfolio
  108. 8.18.5 DRG Diagnostics Recent Developments
  109. 8.19 Epitope Diagnostics
  110. 8.19.1 Epitope Diagnostics Company Information
  111. 8.19.2 Epitope Diagnostics Business Overview
  112. 8.19.3 Epitope Diagnostics Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Epitope Diagnostics Helicobacter Pylori Antigen Test Product Portfolio
  114. 8.19.5 Epitope Diagnostics Recent Developments
  115. 8.20 SD Biosensor
  116. 8.20.1 SD Biosensor Company Information
  117. 8.20.2 SD Biosensor Business Overview
  118. 8.20.3 SD Biosensor Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  119. 8.20.4 SD Biosensor Helicobacter Pylori Antigen Test Product Portfolio
  120. 8.20.5 SD Biosensor Recent Developments
  121. 8.21 DiaSorin
  122. 8.21.1 DiaSorin Company Information
  123. 8.21.2 DiaSorin Business Overview
  124. 8.21.3 DiaSorin Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  125. 8.21.4 DiaSorin Helicobacter Pylori Antigen Test Product Portfolio
  126. 8.21.5 DiaSorin Recent Developments
  127. 8.22 QuidelOrtho
  128. 8.22.1 QuidelOrtho Company Information
  129. 8.22.2 QuidelOrtho Business Overview
  130. 8.22.3 QuidelOrtho Helicobacter Pylori Antigen Test Revenue and Gross Margin (2021-2026)
  131. 8.22.4 QuidelOrtho Helicobacter Pylori Antigen Test Product Portfolio
  132. 8.22.5 QuidelOrtho Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research